BioLineRx begins phase 2 trial for pancreatic cancer treatment By Investing.com
[ad_1] © Reuters. TEL AVIV – BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical company, has initiated the Phase 2 CheMo4METPANC clinical trial, dosing the...